BOSTON, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Natus Medical Incorporated (“Natus” or the “Company”) (NASDAQ: BABY) and certain of its officers and directors violated federal securities laws.
On February 6, 2019, GlassHouse Research released a report which accused Natus of deceptive accounting practices.
This news drove the price of Natus shares down 6.5%. If you have purchased or otherwise acquired Natus securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact attorney Dan DeMaria at (888) 868-2385, by email at dan@blockesq.com, or by visiting http://shareholder.law/natus.
Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation's largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.
This notice may constitute attorney advertising.
CONTACT:
BLOCK & LEVITON LLP
Dan DeMaria
(617) 398-5660 phone
155 Federal Street, Suite 400
Boston, MA 02110
dan@blockesq.com
SOURCE Block & Leviton LLP